Clinical Study

A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squamous Cell Carcinoma.

Posted Date: Feb 8, 2017

  • Investigator: Nooshin Hashemi Sadraei
  • Co-Investigator: Andrea Collins
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this research study is to test the safety of adding metformin to treatment that you will already be getting for your cancer. You will be offered “standard of care” treatment whether you participate in this study or not. The standard of ca

Criteria:

To Be Eligible To Participate, Patients Must Have Head And Neck Cancer That Requires Treatment With Cisplatin And Radiation.

Keywords:

Head & Neck, Ucci-Hn-14-01, Squamous Cell, Cancer, Null

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.